Chemotherapy-induced fatigue is associated with changes in gene expression in the peripheral blood mononuclear cell fraction of patients with locoregional breast cancer
Bárbara Bonaparte Ribas de Alcântara(Faculdade de Medicina do ABC), Auro del Giglio(Faculdade de Medicina do ABC), João Bosco Pesquero(Universidade Federal de São Paulo), Matheus Moreira Perez(Faculdade de Medicina do ABC), Beatriz da Costa Aguiar Alves(Faculdade de Medicina do ABC), Fernando Luiz Affonso Fonseca(Centro Universitário Fundação Santo André), Cláudia Vaz de Melo Sette(Faculdade de Medicina do ABC), Patrícia Varela(Universidade Federal de São Paulo), Felipe Melo Cruz(Instituto Brasileiro de Controle do Câncer), Daniel de Iracema Gomes Cubero(Faculdade de Medicina do ABC)
Cited by 10
Related Papers
Methylene blue in photodynamic therapy: From basic mechanisms to clinical applications
|Photodiagnosis and Photodynamic Therapy|2005|910
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|663
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer
|Journal of Clinical Oncology|2023|332
The biology of cancer-related fatigue: a review of the literature
|Supportive Care in Cancer|2015|305
Cancer-related fatigue: a practical review
|Annals of Oncology|2011|220